INS and Hypoglycemia: First‐generation meal‐time analogues do however have a significant advantage over animal and human insulins,39 because these latter have a prolonged tail of absorption and continue to act long after any food has been absorbed from the gut, enhancing the hypoglycaemia risk in particular into the early part of the night.40